Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 3/20 | 0.51 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.51 |
| ▸ | DEGS1 | O15121 | 3/20 | 0.48 |
| ▸ | FAAH | O00519 | 2/20 | 0.46 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.46 |
| ▸ | CETP | P11597 | 3/20 | 0.46 |
| ▸ | THRB | P10828 | 2/20 | 0.46 |
| ▸ | ASAH1 | Q13510 | 1/20 | 0.43 |
| ▸ | DNM1 | Q05193 | 1/20 | 0.42 |
| ▸ | ASAH2 | Q9NR71 | 1/20 | 0.42 |
| ▸ | KCNK3 | O14649 | 1/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.42 |
| ▸ | CNR2 | P34972 | 1/20 | 0.42 |
| ▸ | BLM | P54132 | 1/20 | 0.42 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.42 |
| ▸ | PLA2G4A | P47712 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5157353 | 1.00 | MEN1 (0.51) | MEN1KMT2ADEGS1FAAHMAPK1 | |
| SCHEMBL557791 | 1.00 | MEN1 (0.51) | MEN1KMT2ADEGS1FAAHMAPK1 | |
| SCHEMBL1623032 | 0.99 | MEN1 (0.54) | MEN1KMT2ADEGS1FAAHMAPK1 | |
| SCHEMBL5821483 | 0.99 | MEN1 (0.54) | MEN1KMT2ADEGS1FAAHMAPK1 | |
| SCHEMBL10958796 | 0.99 | MEN1 (0.54) | MEN1KMT2ADEGS1FAAHMAPK1 | |
| SCHEMBL1623037 | 0.99 | MEN1 (0.54) | MEN1KMT2ADEGS1FAAHMAPK1 | |
| SCHEMBL1623366 | 0.99 | MEN1 (0.54) | MEN1KMT2ADEGS1FAAHMAPK1 | |
| SCHEMBL1622513 | 0.99 | MEN1 (0.54) | MEN1KMT2ADEGS1FAAHMAPK1 | |
| SCHEMBL5185943 | 0.99 | MEN1 (0.54) | MEN1KMT2ADEGS1FAAHMAPK1 | |
| SCHEMBL679503 | 0.99 | MEN1 (0.54) | MEN1KMT2ADEGS1FAAHMAPK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2007104576-A1 | MEDICAMENT COMPRISING N-ACETYLMANNOSAMINE OR DERIVATIVES THEREOF AND ITS USE | MOSETTER, KURT (CH) | 2007-09-20 | — | — | WO | claimed |
| WO-2007104576-A1 | MEDICAMENT COMPRISING N-ACETYLMANNOSAMINE OR DERIVATIVES THEREOF AND ITS USE | MOSETTER, KURT (CH) | 2007-09-20 | — | — | WO | disclosed |
| US-6692931-B1 | MESSENGER SUBSTANCES, SIGNALING SUBSTANCES, PROMOTERS, STIMULATORS AND INITIATORS IN METABOLIC PROCESSES OF ANIMALS AND HUMAN BEINGS, WHICH DIRECTLY OR INDIRECTLY INFLUENCE THESE METABOLIC PROCESSES | Reutter, Werner (DE) | 2004-02-17 | — | — | US | disclosed |
| EP-1131422-A1 | RECOMBINANT GLYCOPROTEINS, METHOD FOR THE PRODUCTION THEREOF, MEDICAMENTS CONTAINING SAID GLYCOPROTEINS AND USE THEREOF | Reutter, Werner, Prof. Dr. (DE) | 2001-09-12 | — | — | EP | disclosed |
| WO-2000029567-A1 | RECOMBINANT GLYCOPROTEINS, METHOD FOR THE PRODUCTION THEREOF, MEDICAMENTS CONTAINING SAID GLYCOPROTEINS AND USE THEREOF | REUTTER WERNER (DE) | 2000-05-25 | — | — | WO | disclosed |